| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
277,430,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sotera Health is a holding company. Through its subsidiaries, Co. provides sterilization, lab testing and advisory services for the healthcare industry with operations primarily in the Americas, Europe and Asia. Co.'s segments are: Sterigenics, which provide outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and applications markets using three main technologies: gamma irradiation, ethylene oxide processing and E-beam irradiation; Nordion, which provides Cobalt-60 used in the sterilization and irradiation processes; and Nelson Labs, which provides outsourced microbiological and analytical chemistry testing and advisory services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
45,344,363 |
45,344,363 |
45,344,363 |
45,344,363 |
| Total Sell Value |
$648,764,474 |
$648,764,474 |
$648,764,474 |
$648,764,474 |
| Total People Sold |
6 |
6 |
6 |
6 |
| Total Sell Transactions |
6 |
6 |
6 |
6 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Klaben Matthew J |
SVP, GC and Secretary |
• – – |
2020-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
31,304 |
31,304 |
|
- |
|
| Leffler Scott J. |
CFO and Treasurer |
• – – |
2020-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
52,173 |
820,426 |
|
- |
|
| Warburg Pincus Llc |
Director |
– • • |
2020-11-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
118,929,897 |
|
- |
|
| Gtcr Partners Xi/a&c Lp |
Director |
– • • |
2020-11-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
79,286,597 |
|
- |
|
| Leffler Scott J. |
CFO and TreasurerOfficer |
• – – |
2020-11-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
768,253 |
|
- |
|
| Klee Ann R. |
Director |
– • – |
2020-11-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,925 |
|
- |
|
| Petras Michael B. Jr. |
Chairman & CEOOfficer |
• • – |
2020-11-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,578,547 |
|
- |
|
| Klaben Matthew J |
SVP, GC and SecretaryOfficer |
• – – |
2020-11-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
438,434 |
|
- |
|
| Rutz Michael P |
President of SterigenicsOffice |
• – – |
2020-11-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
594,957 |
|
- |
|
| Warburg Pincus Partners Gp Llc |
Director |
– • • |
2020-11-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
118,929,897 |
|
- |
|
85 Records found
|
|
Page 4 of 4 |
|
|
